Immunic Inc. buy tamam
Start price
25.03.20
/
50%
€7.50
Target price
04.11.21
€25.00
Performance (%)
17.93%
End price
05.11.21
€8.85
Summary
This prediction ended on 05.11.21 with a price of €8.85. The BUY prediction by tamam finished with a performance of 17.93%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Immunic Inc. | 5.808% | 5.808% | -38.340% | -66.065% |
| iShares Core DAX® | -1.673% | 2.237% | 16.344% | 61.776% |
| iShares Nasdaq 100 | -1.346% | 0.290% | 3.851% | 105.171% |
| iShares Nikkei 225® | -1.529% | 5.863% | 18.286% | 52.222% |
| iShares S&P 500 | -1.702% | 0.697% | 1.755% | 66.580% |
Comments by tamam for this prediction
In the thread Immunic Inc. diskutieren
Immunic (NASDAQ:IMUX) announces positive top-line data from its phase 2 EMPhASIS trial of lead asset, IMU-838, the selective oral DHODH inhibitor, in patients with relapsing-remitting multiple sclerosis (RRMS).
In the thread Trading Immunic Inc.
Die von tamam gewählte maximale Laufzeit wurde überschritten